Page 1913 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

1340 Index

Gastric emptying, 1203 interventional clinical studies, 143–144, Head injury, 1121–1137
Gastric lavage, 1210, 1211 143t, 144t bleeding and transfusion issues, 1128–1129
Gastric varices, 221, 1012 mechanisms of stress hyperglycemia, antiseizure prophylaxis, 1128–1129
Gastritis, 705 142–143, 143f glucocorticoids, 1129
Gastrointestinal acidosis, acid-base balance observational clinical studies, 143 neuromonitoring issues, 1129
and, 973 physiological regulation of blood glucose, cerebral blood flow, 1130–1131, 1130f
Gastrointestinal adaptation in 142, 142f cerebral oxygenation and metabolism,
pregnancy, 1255 sepsis and, 575 1131–1132
Gastrointestinal bleeding, 218–221, 219f spinal injuries and, 1151 brain tissue oxygen monitoring,
Gastrointestinal dysfunction in sepsis, toxicity associated with high glucose 1131–1132, 1132f
565–566 concentrations, 142 jugular venous bulb oximetry, 1131, 1131f
Gastrointestinal hemorrhage, 1008–1021 Glycopeptides, 548, 548t microdialysis, 1132
clinical considerations, 1009–1010, 1009t in febrile neutropenic patients, 612–613 cerebral perfusion pressure and, 1130
lower, 1018–1020, 1019f Glycoprotein Ib platelet receptor deficiency, 846 health care-associated infections, 1136
nonvariceal, 1014–1018 Glycoprotein IIb/IIIa receptor antagonists, hemodynamic monitoring and
upper, 1010 300, 304 management, 1126–1127,
variceal, 1010–1014 Glycylcyclines, 548, 548t 1126f, 1127f
Gastrointestinal infections, Clostridium Goiter and acute airway obstruction, 990 initial stabilization, imaging, and
difficile and, 703–711, 704t thyroid disease and, 990 management, 1124–1125, 1125f
diarrhea, 705–708, 706t Gradenigo syndrome, 664 intracranial pressure monitoring,
esophagitis, 704–705 Graft-versus-host disease (GVHD), 1129–1130, 1130f
gastritis, 705 1294–1295 intravenous fluid and electrolyte
host defenses, 704 acute, 884–885, 884t management, 1127–1128
Gastrointestinal system, electrical trauma chronic, 885 nutrition and metabolic management,
and, 1178 hematopoetic stem cell transplantation 1136–1137
Gastrointestinal toxicities, 897–898 and, 881–890, 882ft glycemic control, 1136–1137
Gastrointestinal tract issues, spinal injuries complications of conditioning regimen, thyroid function, 1137
and, 1152 882–883 paroxysmal sympathetic hyperactivity, 1127
Gastroparesis, 976 general and critical care outcomes in primary and secondary traumatic brain
Gelatin, 572 Hematopoetic Stem Cell Transplant injury, 1124, 1124f
Gemcitabine, 895 (HSCT) recipients, 890 prophylactic hypothermia and induced
Gene expression, apoptosis and, 555 hepatic complications, 888–889 normothermia, 1135
General adaption syndrome, 980 infectious complications, 885–886, 886t respiratory management, 1125–1126
Generalized tetanus, 730 pulmonary complications, 886–888 trauma, mechanisms of injury, 1122–1124,
Genitourinary injuries, 1166–1167 rejection/graft failure, 889 1122f, 1123f
Genitourinary tract issues, spinal injuries relapses, 890 treatment of intracranial hypertension,
and, 1152 renal complications, 889 1132–1135
Gentamicin, 547 prophylaxis, 883 barbiturates, 1135
Gilbert syndrome, 999, 1001 Granulocyte-macrophage colony-stimulating cerebrospinal fluid drainage, 1133
Glasgow Coma Scale (GCS), 832, 832t, factor (GM-CSF), 556 hyperosmolar therapy, 1133–1134
1124–1125, 1125f Granulomatous hepatitis, 618 hyperventilation, 1133
Glasgow Outcome Score, 816 Graves disease, 826 operative management of traumatic
GlideScope™, 390 Grief, managing, 4, 4t brain injury and decompressive
Global cerebral hypoperfusion, 818, 819f Group B streptococcus, 653 craniectomy, 1134–1135
Global end-diastolic volume, 264 Guillain-Barré syndrome (GBS), 671, 821, sedation, analgesia, and paralytics,
Global hypertension, 1076 824–825 1132–1133
Glomerular filtration rate (GFR), 261 venous thromboembolism prophylaxis,
as measure of kidney function, 916 H 1135–1136
Glomerulonephritis, rapidly progressive, 922 H1N1 pandemic, 57 Health care, 113–114
Glomerulosclerosis, 927 HACEK, 595 economic evaluations in, 38
Glomerulotubular balance, 918 Half-life, 1238 Health care associated infections, 1136
Glottis, 404, 405 Haloperidol, 153, 1197 criteria for diagnosis of, 23–24
Glucocorticoids, 338, 877, 980–981 in treating delirium, 762 interventions to prevent, in intensive-care
head injury and, 1129 Halo vest, 1147 unit, 26
for sickle cell disease, 914 Hand-foot syndrome, 901 spinal injuries and, 1151
supplementation in chronic glucocorticoid Hand hygiene in intensive-care unit, 28 Health-care associated pneumonia, 584–585
users, 1059–1060 Hangman fractures, 1147 definition, 584
Glucose and electrolyte balance, Hantaan virus, 742 epidemiology of, 584
maintaining, 840 Hantaviruses, 718, 742 etiologic spectrum and recommended
Glucose dysregulation, 112 Hantavirus pulmonary syndrome, 742 antibiotic therapy, 584–585
Glucose monitoring in burn patients, 1188 Harm, preventable versus inevitable, 32 Health Information Systems (HIS), 55
Glucotoxicity, 975 Hartford Hospital Once Daily Aminoglycoside Health information technology (HIT), 49, 55
Glutamine, 139 nomogram, 547 factors affecting adoption of, 55
Glycemic control, 141–145 Hazard vulnerability analysis (HVA), 57 Health Insurance Portability and
in critically ill patients, 144–145 intensive care units (ICUs) and, 57–58, 58t Accountability Act (HIPAA) (1994),
head injury and, 1136–1137 Head, life-threatening infections of, 676–688 53–54, 129

Index.indd 1340 23-01-2015 15:33:52